XRAY DENTSPLY SIRONA Inc.

Making a lasting impact: Dentsply Sirona announces 5-year partnership agreement with Smile Train and a $5 million donation

Making a lasting impact: Dentsply Sirona announces 5-year partnership agreement with Smile Train and a $5 million donation

Dentsply Sirona, the world’s largest manufacturer of professional dental products, announced the official launch of its partnership with Smile Train, the world’s largest cleft-focused organization. For over 21 years, Smile Train has supported safe and quality cleft care for more than 1.5 million children in over 90 countries around the world. Dentsply Sirona’s commitment aims to advance the future of and access to cleft care.

CHARLOTTE, N.C. , Sept. 24, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), Globally, 1 in 700 babies are born with a cleft lip and/or palate. Clefts can have devastating effects on the quality of life of a child, both physically by compromising the ability to communicate and to eat properly and from social stigma resulting in feelings of anxiety and a lack of self-confidence. A child with a cleft requires more than just surgery. Essential cleft care includes nutrition programs, dental and orthodontic care, speech therapy, and social and emotional support.

Smile Train’s sustainable model empowers local medical professionals to provide free cleft surgery and essential cleft care in their own communities. That’s why Dentsply Sirona is launching this partnership with Smile Train to improve oral health globally and to build a brighter, more sustainable future for children and families affected by cleft worldwide.

We are going beyond traditional financial and equipment donations. The Dentsply Sirona and Smile Train partnership will advance the future of cleft care by:

  • Supporting global treatment standards and best practices for digitized cleft care;
  • Leveraging digital technologies to make treatments more efficient and convenient for children;
  • Providing high quality equipment to develop state-of-the-art centers for cleft treatment;
  • Making our entire online catalog of clinical education courses available to all Smile Train oral health professionals; and
  • Offering financial support for cleft surgeries.

The company is focused on making sure the benefits of our Smile Train partnership have a lasting impact. Therefore, in addition to funding life-changing cleft surgeries and providing free dental equipment, the collaboration focuses on global, oral healthcare training initiatives to equip people in local communities with the skills needed to provide treatment and raise the standard of care to the highest level through Clinical Education and the use of cutting-edge technologies in the long term.

Additionally, the partnership includes the development of an International Smile Train Scholars program, which will support in-person and virtual training and learning opportunities for Smile Train dental partners. A group of 16 scholars are attending DS World 2021, participating in clinical education sessions and growing their professional networks.

“Our partnership with Smile Train will help children around the world gain access to cleft treatment and offer them the chance to live a happy and healthy life. By also focusing on global treatment standards and best practices, donating innovative technology, and supporting the training and development of local healthcare professionals, the partnership will have an empowering impact on communities and will provide access to the best possible cleft care, for years to come,” said Jorge Gomez, CFO and Head of Dentsply Sirona’s Sustainability program “Beyond”. “Smile Train’s focus on comprehensive cleft care and community empowerment is inspiring. We are incredibly proud to partner with them to support their life-changing work.”

“We are pleased to welcome Dentsply Sirona on board as a corporate partner. This five-year partnership comes at a pivotal moment for Smile Train and will help advance the future of cleft care by supporting global treatment standards and best practices for digitalized cleft orthodontics,” said Susannah Schaefer, President & Chief Executive Officer, Smile Train. “We are grateful for Dentsply Sirona’s generous support and look forward to working together to raise awareness about and deepen our impact around cleft.”

About Dentsply Sirona

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry. The Company’s shares of common stock are listed in the United States on Nasdaq under the symbol XRAY. Visit for more information about Dentsply Sirona and its products.

Contact Information

Investors:

Andrea Daley

VP, Investor Relations



 



EN
24/09/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on DENTSPLY SIRONA Inc.

 PRESS RELEASE

Dentsply Sirona Reports Second Quarter 2025 Results

Dentsply Sirona Reports Second Quarter 2025 Results Net sales of $936 million decreased (4.9%), decreased (6.7%) in constant currency including a (3.2%) Byte sales impactGAAP gross margin of 52.4%, GAAP net loss per share of ($0.22)Adjusted gross margin of 55.9%, adjusted EBITDA margin of 21.1%, adjusted EPS of $0.52Executed $550 million debt offeringReaffirmed FY25 outlookLeadership transition with Dan Scavilla appointed CEO effective August 1, 2025 and Matt Garth appointed CFO effective May 30, 2025 CHARLOTTE, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Si...

 PRESS RELEASE

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook CHARLOTTE, N.C., July 21, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or “the Company”) (Nasdaq: XRAY) today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a current member of the Board of Directors of Dentsply Sirona (the “Board”), has been appointed President and Chief Executive Officer, effective A...

 PRESS RELEASE

Dentsply Sirona to Host Second Quarter Conference Call on August 7th

Dentsply Sirona to Host Second Quarter Conference Call on August 7th CHARLOTTE, N.C., July 10, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will host an investor conference call and live webcast on Thursday, August 7, 2025, at 8:30 am ET to review its financial results for the second quarter of fiscal year 2025. The Company will issue a press release and provide a presentation with summary financial information, which will be made available on the Investors section of the Company’s website at prior to t...

 PRESS RELEASE

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated...

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes CHARLOTTE, N.C., June 05, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the “Company”) (Nasdaq: XRAY) today announced it has priced an offering (the “Offering”) of $550 million aggregate principal amount of its 8.375% Junior Subordinated Notes due 2055 (the “notes”). The Offering is expected to close on June 12, 2025, subject to customary closing conditions. The notes will bear interest at a fixed rate of 8.375% per year until September 12, 2030 (the “First Reset Date”). On and after the Fi...

Moody's Ratings assigns Baa3 rating to Dentsply Sirona's proposed hybr...

Moody's Ratings (Moody's) assigned a Baa3 rating to Dentsply Sirona Inc.'s ("Dentsply Sirona") proposed offering of junior subordinated notes ("hybrid"). At the same time, we affirmed Dentsply Sirona's Baa2 issuer rating, Baa2 senior unsecured rating and Prime-2 commercial paper rating. The outlook ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch